TITLE

The Role of Peroxisome Proliferator-Activated Receptor γ in Immune Responses to Enteroaggregative Escherichia coli Infection

AUTHOR(S)
Philipson, Casandra W.; Bassaganya-Riera, Josep; Viladomiu, Monica; Pedragosa, Mireia; Guerrant, Richard L.; Roche, James K.; Hontecillas, Raquel
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Enteroaggregative Escherichia coli (EAEC) is recognized as an emerging cause of persistent diarrhea and enteric disease worldwide. Mucosal immunity towards EAEC infections is incompletely understood due in part to the lack of appropriate animal models. This study presents a new mouse model and investigates the role of peroxisome proliferator-activated receptor gamma (PPARγ) in the modulation of host responses to EAEC in nourished and malnourished mice. Methods/Principal Findings: Wild-type and T cell-specific PPARγ null C57BL/6 mice were fed protein-deficient diets at weaning and challenged with 5×109cfu EAEC strain JM221 to measure colonic gene expression and immune responses to EAEC. Antigen-specific responses to E. coli antigens were measured in nourished and malnourished mice following infection and demonstrated the immunosuppressive effects of malnutrition at the cellular level. At the molecular level, both pharmacological blockade and deletion of PPARγ in T cells resulted in upregulation of TGF-β, IL-6, IL-17 and anti-microbial peptides, enhanced Th17 responses, fewer colonic lesions, faster clearance of EAEC, and improved recovery. The beneficial effects of PPARγ blockade on weight loss and EAEC clearance were abrogated by neutralizing IL-17 in vivo. Conclusions: Our studies provide in vivo evidence supporting the beneficial role of mucosal innate and effector T cell responses on EAEC burden and suggest pharmacological blockade of PPARγ as a novel therapeutic intervention for EAEC infection.
ACCESSION #
87625656

 

Related Articles

  • Cross-Species Gene Expression Analysis of Species Specific Differences in the Preclinical Assessment of Pharmaceutical Compounds. Okyere, John; Oppon, Ekow; Dzidzienyo, Daniel; Sharma, Lav; Ball, Graham // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Animals are frequently used as model systems for determination of safety and efficacy in pharmaceutical research and development. However, significant quantitative and qualitative differences exist between humans and the animal models used in research. This is as a result of genetic variation...

  • PPARδ Activation Protects Endothelial Function in Diabetic Mice. Xiao Yu Tian; Wing Tak Wong; Nanping Wang; Ye Lu; Wai San Cheang; Jian Liu; Limei Liu; Yahan Liu; Susanna Sau-Tuen Lee; Zhen Yu Chen; Cooke, John P.; Xiaoqiang Yao; Yu Huang // Diabetes;Dec2012, Vol. 61 Issue 12, p3285 

    Recent evidence highlights the therapeutic potential of peroxisome proliferator-activated receptor-d (PPARd) agonists to increase insulin sensitivity in diabetes. However, the role of PPARd in regulating vascular function is incompletely characterized. We investigate whether PPARd activation...

  • Ulcerative Colitis Impairs the Acylethanolamide-Based Anti-Inflammatory System Reversal by 5-Aminosalicylic Acid and Glucocorticoids. Suárez, Juan; Romero-Zerbo, Yanina; Márquez, Lucia; Rivera, Patricia; Iglesias, Mar; Bermúdez-Silva, Francisco J.; Andreu, Montserrat; Rodríguez de Fonseca, Fernando // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    Studies in animal models and humans suggest anti-inflammatory roles on the N-acylethanolamide (NAE)-peroxisome proliferators activated receptor alpha (PPARα) system in inflammatory bowel diseases. However, the presence and function of NAE-PPARα signaling system in the ulcerative colitis...

  • SHH signaling mediates the effect of PPAR β/δ on angiogenesis following cerebral ischemia. Yutong Wang; Yunliang Wang; Jinfeng Li; Yuzhen Zhang; Honglei Yin; Bing Han // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 1, p101 

    Aims: This study aimed to investigate whether Sonic Hedgehog (SHH) mediates the effects of peroxisome proliferator-activated receptor beta/delta (PPAR β/δ) on angiogenesis following cerebral ischemia. Methods: A rat middle cerebral artery occlusion (MCAO) model was established. Ischemic...

  • Role of peroxisome proliferator-activated receptor α in atherosclerosis. HENG CAO; GAO WEN; HONGLI LI // Molecular Medicine Reports;2014, Vol. 9 Issue 5, p1755 

    Atherosclerosis is an inflammatory disease involving the immune response. In addition to lowering the cholesterol level, the peroxisome proliferator-activated receptor a (PPAR-α) can prevent atherosclerosis via its pleiotropic anti-inflammatory effects. However, the role of PPAR-α in...

  • A Role for Peroxisome Proliferator-Activated Receptors in the Immunopathology of Schistosomiasis? Anthony, Barrie J.; Allen, Jeremy T.; Li, Yuesheng S.; McManus, Donald P. // PPAR Research;2012, Special section p1 

    Peroxisome proliferator-activated receptors (PPARs) have been demonstrated to have a role in immune regulation. In general, they are anti-inflammatory and promote Th2 type responses, and they are associated with the alternative activation of macrophages. Interestingly, helminth infections, such...

  • The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course. Mwinyi, Jessica; Grete-Wenger, Christa; Eloranta, Jyrki J.; Kullak-Ublick, Gerd A. // PPAR Research;2012, Special section p1 

    PPARγ is a nuclear receptor that regulates numerous pathways including cytokine expression and immune responses and plays an important role in controlling colon inflammation. We aimed at determining the occurring PPARγ SNPs, at predicting the haplotypes, and at determining the frequency...

  • New Insights into the Role of Peroxisome Proliferator-Activated Receptors in Regulating the Inflammatory Response after Tissue Injury. Neher, Miriam D.; Weckbach, Sebastian; Huber-Lang, Markus S.; Stahel, Philip F. // PPAR Research;2012, Special section p1 

    Major trauma results in a strong inflammatory response in injured tissue. This posttraumatic hyperinflammation has been implied in the adverse events leading to a breakdown of host defense mechanisms and ultimately to delayed organ failure. Ligands to peroxisome proliferator-activated receptors...

  • PPAR-γ激动剂吡咯列酮对卵蛋白激发气道变应性炎症的调节作用. 方 萍; 吴晓明; 李满祥; 史红阳; 张永红; 卢佳美 // Journal of Xi'an Jiaotong University (Medical Sciences);Mar2014, Vol. 35 Issue 2, p235 

    Objective To evaluate the immunomodulation of peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist pioglitazone (PGZ) in ovalbumin (OVA)-induced airway allergic inflammation in mice. Methods BALB/c mice received OVA sensitization followed by OVA intranasal challenge. Mice in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics